Summary & Overview
CPT 4151F: Hepatitis C Patient Not on Antiviral Therapy
CPT code 4151F documents that a patient with hepatitis C has not started or is not receiving antiviral therapy. This administrative clinical code records treatment status rather than a specific procedure and is used across ambulatory, specialty, and primary care settings to capture care gaps, contraindications, patient choice, or other reasons for lack of therapy. Nationally, consistent use of this code supports quality measurement, population health tracking, and payer coverage decisions for hepatitis C management.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code's clinical meaning, typical service settings, and how it fits into documentation workflows. The publication summarizes common use cases, expected impacts on performance measurement, and where this status code intersects with broader hepatitis C care pathways. Benchmarks, payer coverage practices, and policy updates are described where available; when specific data elements are not provided in the input, the text notes that the data are not available. The content is written for a national audience and focuses on operational and documentation implications rather than clinical decision recommendations.
Billing Code Overview
CPT code 4151F indicates that a patient with hepatitis C is not currently receiving antiviral therapy or has not started antiviral therapy for reasons that may vary. The code documents the clinical status regarding antiviral treatment initiation for hepatitis C infection.
Service type: Care coordination / treatment status documentation
Typical site of service: Outpatient clinic, specialty infectious disease or hepatology clinic, primary care setting
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult diagnosed with chronic hepatitis C virus (HCV) infection who has not initiated antiviral therapy. The patient presents to the hepatology or infectious disease clinic for evaluation of treatment candidacy. Clinical workflow includes history and physical examination focused on liver disease symptoms, review of prior treatment attempts, assessment of contraindications (active substance use, comorbidities, pregnancy, drug interactions), baseline laboratory evaluation (HCV RNA, genotype, liver function tests, CBC, renal function), and noninvasive liver fibrosis assessment (transient elastography or fibrosis biomarkers). The provider documents reasons for not starting antiviral therapy (for example, patient refusal, deferral for pregnancy, active unstable psychiatric condition, ongoing illicit substance use without stabilization, insurance/coverage barriers, or planned delay pending specialist consultation). Counseling about disease course, transmission prevention, and follow-up plans is provided. The encounter result is coded with 4151F to indicate that antiviral therapy for hepatitis C was not started or the patient is not on antiviral therapy, with supporting documentation of the specific reason in the medical record.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the day of a procedure | Use when a distinct E/M service is provided the same day as a procedure or service billed separately |
59 | Distinct procedural service | Use if a separate and unrelated procedure is performed on the same day as another procedure |
76 | Repeat procedure or service by same physician | Use when a procedure or service is repeated by the same provider within the global period |
77 | Repeat procedure or service by another physician | Use when a procedure or service is repeated by a different provider within the global period |
21 | Prolonged evaluation and management service | Use when extended time is documented for counseling and coordination of care related to non-initiation of therapy |
52 | Reduced services | Use if a listed service is partially reduced or not completed as documented |
GT | Via interactive audio and video telecommunications (telehealth) | Use when the encounter is delivered as a synchronous telehealth visit |
95 | Synchronous telemedicine service rendered via real-time interactive audio and video | Use for telehealth encounters meeting payer telemedicine requirements |
GQ | Via asynchronous telecommunications system | Use when services are delivered via store-and-forward technologies if allowed by payer |
AI | Principal physician of record/attending of record | Use when reporting attending physician responsibility in certain billing systems |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
208000000X | Family Medicine | Primary care clinicians who often identify HCV and coordinate care |
207R00000X | Internal Medicine | General internists managing chronic HCV evaluation and referral |
207RH0000X | Infectious Disease | Specialists in viral hepatitis evaluation and antiviral therapy management |
2080P0206X | Gastroenterology | Gastroenterologists or hepatologists who manage liver disease and HCV treatment |
2084P0800X | Hepatology | Subspecialists focused on advanced liver disease and antiviral treatment planning |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
B18.2 | Chronic viral hepatitis C | Primary diagnosis indicating chronic HCV infection and the main reason antiviral therapy would be considered |
Z71.89 | Other specified counseling | Used for documented counseling about HCV treatment deferral or transmission prevention |
Z20.828 | Contact with and (suspected) exposure to other viral communicable diseases | May be used when exposure risk counseling or public health reporting is relevant |
O09.82 | Supervision of pregnancy with other high-risk pregnancy, second trimester | Relevant when antiviral therapy is deferred due to pregnancy until postpartum or later gestational timing |
F10.20 | Alcohol dependence, uncomplicated | Documented active substance use disorder that may lead to deferral of antiviral therapy until stabilization |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
99401 | Preventive medicine counseling and/or risk factor reduction intervention(s) (15 minutes) | Brief counseling about HCV transmission prevention and treatment options when therapy not started |
99406 | Smoking and tobacco use cessation counseling visit, intermediate (greater than 3 minutes up to 10 minutes) | Counseling for modifiable risks (e.g., tobacco) that may affect liver health when delaying therapy |
87622 | Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C virus, amplified probe technique, quantification | Baseline or follow-up HCV RNA testing used in evaluation when therapy is deferred |
91200 | Transient elastography (FibroScan) for liver stiffness measurement | Noninvasive fibrosis assessment commonly performed when considering HCV treatment timing |
99499 | Unlisted evaluation and management service | Use for nonstandard counseling or care coordination services related to complex reasons for not starting therapy |